Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
Depression is a common comorbid condition in Parkinson’s disease (PD). Patients with depression have a two-fold increased risk to develop PD. Further, depression symptoms often precede motor symptoms in PD and are frequent at all stages of the disease. However, the influence of a depressive state on...
Main Authors: | Nicoletta Schintu, Xiaoqun Zhang, Nikolas Stroth, Aleksander A. Mathé, Per E. Andrén, Per Svenningsson |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphar.2020.00304/full |
Similar Items
-
Behavioral effects of zonisamide on L-DOPA-induced dyskinesia in Parkinson's disease model mice
by: Hiromi Sano, et al.
Published: (2023-06-01) -
Corrigendum: Advances in non-dopaminergic pharmacological treatments of Parkinson’s disease
by: Sandy eStayte, et al.
Published: (2014-08-01) -
Advances in non-dopaminergic pharmacological treatments of Parkinson's disease
by: Sandy eStayte, et al.
Published: (2014-05-01) -
Relation of 18-F-Dopa PET with hypokinesia-rigidity, tremor and freezing in Parkinson’s disease
by: Angelina R.A. Pikstra, et al.
Published: (2016-01-01) -
7-Nitroindazole reduces L-DOPA-induced dyskinesias in non-human Parkinsonian primate
by: M. T. Herrero, et al.
Published: (2023-05-01)